The monoclonal antitoxin antibodies (actoxumab-bezlotoxumab) treatment facilitates normalization of the gut microbiota of mice with Clostridium difficile infection

  1. Džunková, M.
  2. D'Auria, G.
  3. Xu, H.
  4. Huang, J.
  5. Duan, Y.
  6. Moya, A.
  7. Kelly, C.P.
  8. Chen, X.
Journal:
Frontiers in Cellular and Infection Microbiology

ISSN: 2235-2988

Year of publication: 2016

Volume: 6

Issue: OCT

Type: Article

DOI: 10.3389/FCIMB.2016.00119 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus